• Final Mile

Decision making among people living with Parkinson’s Disease

We had a very meaningful opportunity to partner with UCB Pharma on understanding what drives treatment decisions among Parkinson’s patients. We were mandated by UCB to use Behavioral Science principles to explain treatment related decisions.

Considering the sensitive nature of the audience, we had to develop appropriate market research methods. This was a great case of Client and Consulting company partnership where a lot of stimulu was co-created. The study, covering patients in the U.K, France and the United States threw up powerful findings on the role of subjectivity, goals, preferences and self expertise in decision making.

You can read more here

2 views0 comments

Recent Posts

See All

The current COVID-19 situation is bound to create an immediate impact on delinquency rates in the financial services sector. Financial institutions around the world will need adopt proactive strategic